Host Dr. Elizabeth Economy interviews Dr. Chenjian Li, discussing the fundamental differences between the Chinese and US systems. He highlights China's rapid progress in biotech and pharmaceutical development, predicting the country may produce its first truly innovative drug within five years.  While the U.S. excels at "zero-to-one" grassroots innovation stemming from decades of basic research, China has traditionally focused on "one-to-100" government-supported scaling and is now increasingly investing in breakthrough innovation. The conversation concludes with Dr. Li's recommendations for U.S. competitiveness: continuing robust basic science funding, maintaining large-scale translational research programs, and preserving America's traditional openness to global talent, which he argues brings not just technical expertise but also scientific thinking and open inquiry to societies worldwide.

Recorded on October 1, 2025.

ABOUT THE SPEAKERS

Dr. Chenjian Li is a Research Fellow at the Hoover Institution of Stanford University. He is taking a leave of absence from the position of University Chair Professor at Peking University.

Elizabeth Economy is the Hargrove Senior Fellow and co-director of the Program on the US, China, and the World at the Hoover Institution. From 2021-2023, she took leave from Hoover to serve as the senior advisor for China to the US Secretary of Commerce. Before joining Hoover, she was the C.V. Starr Senior Fellow and director, Asia Studies at the Council on Foreign Relations. She is the author of four books on China, including most recently The World According to China (Polity, 2021), and the co-editor of two volumes. She serves on the boards of the National Endowment for Democracy and the National Committee on US-China Relations. She is a member of the Aspen Strategy Group and Council on Foreign Relations and serves as a book reviewer for Foreign Affairs.  

ABOUT THE SERIES

China Considered with Elizabeth Economy is a Hoover Institution podcast series that features in-depth conversations with leading political figures, scholars, and activists from around the world. The series explores the ideas, events, and forces shaping China’s future and its global relationships, offering high-level expertise, clear-eyed analysis, and valuable insights to demystify China’s evolving dynamics and what they may mean for ordinary citizens and key decision makers across societies, governments, and the private sector.

Expand
overlay image